Approval · Notice of Compliance 8606 · 2007
MILBEMAX: Notice of Compliance 8606
Issued February 21, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8606
- Date
- February 21, 2007
- Company
- Novartis Animal Health Canada Inc.Mississauga, Ontario, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Antiparasitic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MILBEMAX | 02291959 | Marketed |
Medicinal ingredients
- MILBEMYCIN OXIME 16 MG per TAB
- PRAZIQUANTEL 40 MG per TAB